Webinar Series on Augmenting US India Trade Relations - 2020 -2022
The Indian healthcare sector is expected to reach Rs 19,56,920 crore (US$ 280 billion) by 2020. Rising income level, greater health awareness, increased precedence of lifestyle diseases and improved access to insurance would be the key contributors to growth
- Revamping the existing guidelines for setting up medical and pharmaceutical education and research methods as per future methodologies. There is a need to encourage case-based learning and research. This method of education and research gives a great difference in learning outcomes. Emphases needs to be for exchange programs of students and research fellows both in education and research between US and India.
- Indian Pharmaceuticals is a sunrise industry with a competitive advantage for India globally. we should leverage India's position by unleashing entrepreneur spirit the bullish outlook for health care segment is now taking India in a forward momentum. The market size of India in Pharmaceuticals alone is estimated to be $100 billion and medical devices is $25 billion by 2025. Now with amendment in FDI policy where one can invest up to 100% specially if it is medical devices segment where India is importing 80% of medical devices.
- India is looking towards growth tenure as 55 billion US dollar of product line is going off patents and this will certainly help India accelerate a higher market share and exports. America, Europe, Japan, South Korea and many countries are planning to shift their manufacturing units out of China. India can and can become the worlds largest hub for Healthcare manufacturing and distribution. Now is the time for Industry Leaders, academia and Government to come together cash in on opportunity.
Webinar in the series on US India Trade Relations 2020 -August 29th, 2020
Topic: "Augmenting US-India Relations in Healthcare under Covid Challenge" on 29th August 2020 at 10:30 AM EST (NY) and 8.00 PM IST (Delhi).
Topic: "Augmenting US-India Relations in Healthcare under Covid Challenge" on 29th August 2020 at 10:30 AM EST (NY) and 8.00 PM IST (Delhi).
The following is the list of our panelist:
- Organizer: Mr. H S Panaser, Chairman, Global Indian Trade and Cultural Council, USA
1. Hon. Randhir Jaiswal , Consulate General of India, NY
2.Mr. Sai D Prasad, President Q.C, Bharat Biotech, Hyderabad, India
3.Mr. Sanjit Singh Lamba, Ex. MD. Eisai Pharma, India
4.Dr. H S Koahia, Commissioner FDCA, Gujarat, India
5.Mr. S. Khanna, Hon.National Secretary, Indian Pharmaceutical Association, India
6.Dr. Himanshu Bhatia, CEO, Ricovr Healthcare, USA
7. Dr. Akash Mathur, CEO, Stellence Pharmascience, India
8.Prof. Inderjit Saluja, Editor, The Indian Panorama, NY, USA, Media
- Organizer: Mr. H S Panaser, Chairman, Global Indian Trade and Cultural Council, USA
1. Hon. Randhir Jaiswal , Consulate General of India, NY
2.Mr. Sai D Prasad, President Q.C, Bharat Biotech, Hyderabad, India
3.Mr. Sanjit Singh Lamba, Ex. MD. Eisai Pharma, India
4.Dr. H S Koahia, Commissioner FDCA, Gujarat, India
5.Mr. S. Khanna, Hon.National Secretary, Indian Pharmaceutical Association, India
6.Dr. Himanshu Bhatia, CEO, Ricovr Healthcare, USA
7. Dr. Akash Mathur, CEO, Stellence Pharmascience, India
8.Prof. Inderjit Saluja, Editor, The Indian Panorama, NY, USA, Media
Webinar in the series on US India Trade Relations 2020 - July 1, 2020
Topic: "Augmenting US-India Relations in Pharmaceuticals under Covid Challenge" on 1st July 2020 at 10:30 AM EST (NY) and 8.00 PM IST (Delhi).
Register at gitcc.c3@gmail.com
The following is the list of our panelist:
- Organizer: Mr. H S Panaser, Chairman, Global Indian Trade and Cultural Council, USA
1. Mr. D. P Misra, Consul (Trade), Consulate General of India, NY
2. Prof. Subroto Chatterjee, John Hopkins, USA
3. Mr. Roopesh Bhardwaj, Ex-COO, Bharat Serum, India
4. Dr. H.K Koshia, Commissioner, FDCA, Gujarat, India
5. Mr. Anand Krishnamurthy , CEO Coolsoft LLC, USA (AI & ML)
6. Mr. Suresh Khanna, Past President, Karnataka Drug & Pharmaceuticals Manufacturers Association
7. Mr.Gary S. Pasricha, Managing partner of the law firm of Pasricha & Patel LLC.
8. Mr. Ajit Chawla, Sr. Vice President, Birlasoft, India
Media Representative: Prof. Inderjit Saluja, NY, US
- Organizer: Mr. H S Panaser, Chairman, Global Indian Trade and Cultural Council, USA
1. Mr. D. P Misra, Consul (Trade), Consulate General of India, NY
2. Prof. Subroto Chatterjee, John Hopkins, USA
3. Mr. Roopesh Bhardwaj, Ex-COO, Bharat Serum, India
4. Dr. H.K Koshia, Commissioner, FDCA, Gujarat, India
5. Mr. Anand Krishnamurthy , CEO Coolsoft LLC, USA (AI & ML)
6. Mr. Suresh Khanna, Past President, Karnataka Drug & Pharmaceuticals Manufacturers Association
7. Mr.Gary S. Pasricha, Managing partner of the law firm of Pasricha & Patel LLC.
8. Mr. Ajit Chawla, Sr. Vice President, Birlasoft, India
Media Representative: Prof. Inderjit Saluja, NY, US
Webinar in the series on US India Trade Relations 2020 - June 1, 2020
Topic: "Augmenting US-India Healthcare Relations under Covid Challenge" on 1st June 2020 at 10:30 AM EST (NY) and 8.00 PM IST (Delhi).
- The following is the list of people on the panel :
- Hon. Sandeep Chakravorty, Consulate General of India, NY, Chief Guest
- Organizer: Mr. H S Panaser, Chairman, Global Indian Trade and Cultural Council, USA
1. Mr. T. Srinivas, CFO, Bharat Biotech, Hyderabad, India
2. Mr. Roop Singh, Chief Business Officer, Birlasoft, USA
3.Prof. Charles N Pozner, MD, Emergency Medicine, Harvard University, USA
4.Prof.(Dr) T.R. Bhardawaj, Vice Chancellor, Baddi University (Pharmaceuticals),India
5. Prof,(Dr) Pradeep Gupta, Burroghs Wellcome Professor of Pharmaceuticals, USciences, Philadelphia, PA, USA
6. Prof.(Dr) Saranjit Singh, Pharmaceutical Scientist, National Institute and Pharmaceutical Education and Research , Mohali, Punjab, India
7. Prof.(Dr) Kanwaljit Chopra, Chairperson, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
8. Mr. Vivek Padgaonkar, Director- Project & Policy , OPPI (Organization of Pharmaceutical Producers of India)
9. Mr. Yash Dani, VP, Fulton Bank, NJ, USA
10. Prof. Inderjit Saluja, Editor, The Indian Panorama, NY, USA, Media
URL for Webinar site: https://inspiring-franklin-052970.netlify.app
- Hon. Sandeep Chakravorty, Consulate General of India, NY, Chief Guest
- Organizer: Mr. H S Panaser, Chairman, Global Indian Trade and Cultural Council, USA
1. Mr. T. Srinivas, CFO, Bharat Biotech, Hyderabad, India
2. Mr. Roop Singh, Chief Business Officer, Birlasoft, USA
3.Prof. Charles N Pozner, MD, Emergency Medicine, Harvard University, USA
4.Prof.(Dr) T.R. Bhardawaj, Vice Chancellor, Baddi University (Pharmaceuticals),India
5. Prof,(Dr) Pradeep Gupta, Burroghs Wellcome Professor of Pharmaceuticals, USciences, Philadelphia, PA, USA
6. Prof.(Dr) Saranjit Singh, Pharmaceutical Scientist, National Institute and Pharmaceutical Education and Research , Mohali, Punjab, India
7. Prof.(Dr) Kanwaljit Chopra, Chairperson, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
8. Mr. Vivek Padgaonkar, Director- Project & Policy , OPPI (Organization of Pharmaceutical Producers of India)
9. Mr. Yash Dani, VP, Fulton Bank, NJ, USA
10. Prof. Inderjit Saluja, Editor, The Indian Panorama, NY, USA, Media
URL for Webinar site: https://inspiring-franklin-052970.netlify.app
Webinar with Punjabi Chamber of Commerce, December 12, 202
Topic:"Punjab 20 years: The past and the future on December 12, 2020 at 9:30 AM EST (NY) and 8.00 PM IST (Delhi).
Topic:"Punjab 20 years: The past and the future on December 12, 2020 at 9:30 AM EST (NY) and 8.00 PM IST (Delhi).